Showing posts with label treatment of spinal muscular atrophy (SMA) in adults and children 2 months of age and older.. Show all posts
Showing posts with label treatment of spinal muscular atrophy (SMA) in adults and children 2 months of age and older.. Show all posts
Wednesday, December 30, 2020

FDA Approves Evrysdi (risdiplam) for Treatment of Spinal Muscular Atrophy (SMA) in Adults and Children 2 Months and Older

›
Genentech, a member of the Roche Group, announced the U.S. Food and Drug Administration (FDA) approval of Evrysdi (risdiplam) for treatment ...